Can cycloserine capsules and prothionamide be used together?

Cycloserine (Cycloserine) and prothionamide (Ethionamide) are often considered for combined use in the treatment of drug-resistant tuberculosis However, clinicians need to fully evaluate drug interactions and patient tolerance when combining regimens. The mechanisms of action of the two are different: cycloserine interferes with bacterial cell wall synthesis, while prothionamide affects the growth of Mycobacterium tuberculosis by inhibiting the fatty acid synthesis pathway. Therefore, combined use can theoretically enhance the antibacterial spectrum and reduce the risk of drug resistance.

However, combined use also brings potential additive risks of adverse reactions. Cycloserine may cause central nervous system side effects, such as headache, insomnia, hallucinations, etc.; prothionamide may cause gastrointestinal discomfort, abnormal liver function and neurotoxicity. When used together, patients need to closely monitor liver function and neuropsychiatric status to prevent increased toxicity or poisoning events. Especially in elderly patients or people with liver and kidney dysfunction, the dose should be adjusted carefully and blood and neurological function indicators should be reviewed regularly.

Clinical experience shows that cycloserine and prothionamide can be used together under strict monitoring conditions, but it must be done under the guidance of a professional doctor to avoid increasing or decreasing the dose on your own or stopping the drug at will. Combination regimens are often used as second-line treatment options for drug-resistant or complicated TB and are not suitable for all patients. Doctors will develop an individualized plan based on the patient's condition, previous medication history, type of drug resistance, and potential side effects to balance efficacy and safety.

In short, cycloserine capsules and prothionamide can be used in combination, but it must be done under strict clinical supervision, paying attention to drug interactions, liver and kidney function, and mental and neurological status monitoring to ensure maximum efficacy and reduce potential risks. Patients should closely cooperate with medical advice during use and report any adverse reactions in a timely manner to ensure safety and continuity of treatment.

Reference materials:https://en.wikipedia.org/wiki/Cycloserine